Pregabalin Capsule
Product Images NDC 72189-328

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 72189-328). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fhtyfgh (72189 0328)

Fhtyfgh (72189 0328)
Label for Pregabalin C-IV capsules, 225 mg strength, containing 60 capsules per bottle. The label includes dosing instructions, storage conditions, a caution statement about federal law prohibiting transfer, and manufacturer information for Direct Rx and Seizure Pharmaceuticals. The label also displays the product NDC 72189-328 and barcode details.*
FDA Label Image

72189 328 60

72189 328 60
Pregabalin C-V 225 mg capsule label showing a yellow and white design. The label identifies the product as 225 mg strength with 90 capsules in the package. It states the generic for Lyrica, containing 225 mg pregabalin per capsule. The labeler is Direct Rx, with NDC 72189-328.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.